| VA11987 |
928326-83-4 |
BIBF-1120 |
C31H33N5O4 |
| VA11989 |
467459-31-0 |
1H-Indole-3-ethanamine, 6-fluoro-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]- |
C20H19N2OF5 |
| VA11988 |
262368-30-9 |
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide |
C14H22N4O |
| VA11990 |
508233-74-7 |
Mirtazapine Related Compound D |
C17H17N3O |
| VA11991 |
845614-11-1 |
Methanone, [4-[3-fluoro-5-(trifluoromethyl)-2-pyridinyl]-1-piperazinyl][5-(methylsulfonyl)- |
C21H20N3O4F7S |
| VA11992 |
1194508-25-2 |
Edivoxetine |
|
| VA11994 |
603139-19-1 |
Odanacatib |
C25H27F4N3O3S |
| VA11995 |
929916-05-2 |
DG 051 (free base) |
|
| VA11993 |
839712-12-8 |
Urea,
N'-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N
-dimethyl- |
C21H32Cl2N4O |
| VA11996 |
393105-53-8 |
1H-Indole-3-aceticacid, a-oxo-1-(phenylmethyl)-5-[4-(trifluoromethoxy)phenyl]- |
C24H16NO4F3 |
| VA11998 |
330942-05-7 |
Betrixaban |
C23H22N5O3Cl |
| VA11997 |
1050477-31-0 |
BAY94-8862 |
|
| VA12000 |
875446-37-0 |
Anacetrapib |
C30H25F10NO3 |
| VA11999 |
705260-08-8 |
SCH 530348 (H2SO4 Salt) |
C29H33N2O4F.H2O4S |
| VA12002 |
850140-72-6 |
Afatinib |
485.94 |
| VA12003 |
870281-82-6 |
CAL101 |
|
| VA12004 |
1061353-68-1 |
PND-1186 |
|
| VA12005 |
1032754-93-0 |
GDC0980 |
C23H30N8O3S |
| VA12001 |
842133-18-0 |
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol |
C24H25FO5S |
| VA12006 |
755038-65-4 |
BI 6727; Volasertib |
C34H50N8O3 |
| VA12008 |
319460-85-0 |
Axitinib |
C22H18N4Os |
| VA12007 |
915769-50-5 |
Dovitinib |
C21H21N6OF.C3H6O3.H2O |
| VA12009 |
915087-33-1 |
MDV-3100 |
|
| VA12010 |
936091-26-8 |
N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
C27H36N6O3S |
| VA12011 |
1056634-68-4 |
CYT 387 |
C23H22N6O2 |
| VA12012 |
941678-49-5 |
Ruxolitinib |
|
| VA12014 |
918504-65-1 |
PLX4032 |
|
| VA12015 |
1028486-01-2 |
4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid |
C27H20ClFN4O4 |
| VA12013 |
19171-19-8 |
Pomalidomide |
C13H11N3O4 |
| VA12016 |
1110813-31-4 |
pf-299804 |
|
| VA12017 |
905854-02-6 |
2,5-Pyrrolidinedione,3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)- |
C23H19N3O2 |
| VA12019 |
1202757-89-8 |
AVL-292 (CC-292) |
|
| VA12020 |
936563-96-1 |
PCI-32765 |
|
| VA12018 |
1202759-32-7 |
CNX-774 |
|
| VA12021 |
175414-77-4 |
Voreloxin |
C18H19N5O4S |
| VA12023 |
849217-68-1 |
XL184 |
|
| VA12024 |
923604-59-5 |
(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1 |
749.94 |
| VA12022 |
763113-22-0 |
Olaparib |
C24H23FN4O3 |
| VA12025 |
441798-33-0 |
Macitentan |
C19H20Br2N6O4S |
| VA12026 |
278779-30-9 |
GW 4064 |
C28H22NO4Cl3 |
